![Clinical relevance of targeting the gastrin releasing peptide receptor, somatostatin receptor 2 or chemokine c-x-c motif 4 in breast cancer for imaging and therapy]()
Clinical relevance of targeting the gastrin releasing peptide receptor, somatostatin receptor 2 or chemokine c-x-c motif 4 in breast cancer for imaging and therapyDalm, S.; Sieuwerts, A.; Look, M.; Melis, M.; van Deurzen, C.; Foekens, J.; de Jong, M.; Martens, J. · Journal of Nuclear Medicine · 2015